Taniguchi K, Tsubaki K, Take K, Okumura K, Terai T, Shiokawa Y
New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan.
Chem Pharm Bull (Tokyo). 1994 Apr;42(4):896-902. doi: 10.1248/cpb.42.896.
As part of our search for new agents for the treatment of overactive detrusor, 2,3- and 3,4-diphenylcyclopentylamines (3), 2,3-diphenyl-2-cyclopentenylamines (4), and related compounds (5 and 18) were synthesized and evaluated for inhibitory activity (i.v.) against urinary bladder rhythmic contraction in rats. Among them, some compounds involving N-tert-butyl-2,3-diphenyl-2-cyclopentenylamine (4b) exhibited inhibitory activity against bladder contraction superior to that of terodiline (2). Mydriatic activity (i.v.) of compound 4b in rats, an index of its side effects due to antimuscarinic activity, was found to be relatively weak in comparison with its inhibitory activity against bladder contraction. The pharmacological profile of 4b was examined in comparison with that of terodiline. Most of the objective amines (3, 4, 5) were synthesized by preparation of Schiff bases from the corresponding cyclic ketones (6, 7, 8) and amines in the presence of TiCl4 in CH2Cl2 and subsequent reduction with NaBH4 in the presence of MeOH in one pot (method A).
作为我们寻找治疗逼尿肌过度活动新药物的一部分,合成了2,3-和3,4-二苯基环戊胺(3)、2,3-二苯基-2-环戊烯胺(4)及相关化合物(5和18),并评估了它们静脉注射对大鼠膀胱节律性收缩的抑制活性。其中,一些含有N-叔丁基-2,3-二苯基-2-环戊烯胺(4b)的化合物对膀胱收缩的抑制活性优于特罗地林(2)。发现化合物4b在大鼠体内的散瞳活性(静脉注射),作为其抗毒蕈碱活性所致副作用的一个指标,与其对膀胱收缩的抑制活性相比相对较弱。将4b的药理学特征与特罗地林的进行了比较。大多数目标胺(3、4、5)通过在二氯甲烷中,在四氯化钛存在下,由相应的环状酮(6、7、8)与胺制备席夫碱,随后在甲醇存在下用硼氢化钠在一个反应釜中一锅法还原(方法A)来合成。